)
Sam Rothstein, PhD
CEO and cofounder
DuoOncology
Dr. Sam Rothstein, PhD is the CEO and cofounder of Duo Oncology. He has 20 years of experience researching and developing nanoparticle products like the ones licensed by Duo Oncology. Since founding and bootstrapping his first company in 2010, a particle CDMO, Dr. Rothstein has continuously worked in life science startups as a CSO or CEO. During this time, he led $7 million of contracts and Small Business Innovation Research projects developing particle drug products. As a CEO, he has also raised over $5M in private investment since 2020. Prior to founding Duo Oncology, Dr. Rothstein began working at the interface of cancer immunotherapy and drug delivery as the CEO of Qrono Inc in 2017. Dr. Rothstein holds chemical engineering degrees from Bucknell University and the University of Pittsburgh.
Sessions
-
22-Jun-2026Theater 2Duo Oncology
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}